It will be interesting to see when Khosla Ventures deploys the funds, and which lucky startups will benefit.
Venture
North American startup investment fell sharply in the fourth quarter, closing out 2022 with funding far below the prior year’s record-setting levels.
Despite last year’s decline in venture capital investment, the first week of the new year saw some sizable deals.
As we head into 2023 with recession fears top of mind, here are a few of 91¾«Æ· News’ top predictions for what the new year has in store, based...
While 2022’s funding numbers couldn’t hope to live up to the previous year’s incredible run, they still looked better than 2020’s pandemic swoon. But...
Although security needs around software development, applications and data remain, cybersecurity startups likely will continue to battle against a...
Venture and growth investors in private companies scaled back their investment pace significantly in the latter half of 2022, signaling a slower...
SpaceX, Elon Musk’s rocket and satellite company, aims to raise a fresh $750 million round at a $137 billion valuation, according to reports.
The "omics" — genomics, transcriptomics, metabolomics and proteomics — are booming in biotech, with more big raises expected in 2023.
Dealmakers think 2023 could see a significant jump in M&A volume as companies’ options for money and exits dwindle.
Despite 2022's pullback in venture capital funding, 10 companies in the U.S. still broke the $1 billion barrier in individual raises.


67.1K Followers